Huawei has announced the inclusion of a high blood sugar assessment feature, also known as hyperglycemia, for their forthcoming Huawei Watch 4 series. This development is a significant breakthrough as the new range of smart wearables is set to debut in China on May 18th.
The CEO of Huawei’s Consumer Business Group, Yu Chengdong, made this announcement, confirming that the Huawei Watch 4 series would be equipped with advanced technology for assessing the risk of high blood sugar. This cutting-edge innovation is another win for Huawei as a frontrunner in the smartwatch industry.
Hyperglycemia
Hyperglycemia is the technical term for high blood glucose (blood sugar). High blood glucose happens when the body has too little insulin or when the body can’t use insulin properly.
Details
The Huawei CEO shared an image clarifying that the new product is not a medical device, and any data and results obtained from its measurements are for reference purposes only, and should not be used as the basis for any diagnosis or treatment. This disclaimer is standard for all health-related smartwatches promoted in the market.
To use this feature, users must participate in a blood sugar health research program initiated by a professional medical institution. It is important to note that this program is not available for users under 18 years old, those with type I diabetes, gestational diabetes, and other specific types of diabetes.
The watch’s user interface displays the feature name “hyperglycemia risk assessment” and provides a risk level label such as “medium risk.” The watch also identifies the risk factors such as short-term blood sugar fluctuations. Additionally, the watch offers advice on what to avoid at this risk level, such as excessive intake of high-sugar, high-oil, and high-fat diets, which may lead to an increased risk of high blood sugar.
If users want to restart the assessment process, they can do so by clicking on the “Start a new round of evaluation” button located at the bottom of the screen.
Huawei will collect user data over a period of time to assess their current blood sugar health. This novel approach to blood sugar monitoring is non-invasive and relies heavily on advanced hardware and software technologies.
China only
The Watch 4 series was recently launched by Huawei for consumers worldwide, but the company has not announced the high blood sugar assessment feature for this release. It appears that this feature is currently limited to the Chinese market.
It is possible that the company is still in the research phase and will be gathering feedback from users to improve the Huawei Watch 4 series’ blood sugar assessment capabilities. Therefore, the limited availability of this feature is understandable at this time.
